Analysis of risk factors for the development of thrombotic complications in antiphospholipid antibody positive lupus patients
Authors:
- 1 January 2007
- journal article
- research article
- Published by SAGE Publications in Lupus
- Vol. 16 (1) , 39-45
Abstract
The objective of this study was to characterize risk factors for thrombotic events in lupus patients. A total of 272 lupus patients were followed up for five years during which the presence of aPL antibodies [anticardiolipin (aCL), anti-beta2-glycoprotein I (aβ2GPI) and lupus anticoagulant (LAC)] were determined, and all thrombotic incidents and antithrombotic therapy-related data were collected. At baseline, three groups were constituted, an aPL–group with 107 aPL negative patients, an aPL+ group with 81 aPL positive patients without clinical thrombosis and a secondary antiphospholipid syndrome (APS) group with 84 aPL+ patients who met the Sapporo criteria. LAC was more common in the APS than the aPL+ group (32.1% versus 9.9%, P < 0.001). The prevalence of clinical thrombotic events was significantly higher when all three types of aPL were present compared to only aCL positive cases. During follow up, aPL appeared in 7.5% of the aPL - group, and 2.8% of this group had thrombotic complications. In the aPL + group, thrombotic events reoccurred in 1.9% of those receiving antithrombotic prophylaxis and 6.9% of those without primary prophylaxis. Despite anticoagulant therapy, thrombotic events reoccurred in 8.3% of the APS group. These findings indicate that LAC, constant and cumulative presence of aPL and previous thrombosis are positive predictors for the development of thrombotic complication in lupus patients.Keywords
This publication has 34 references indexed in Scilit:
- International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)Journal of Thrombosis and Haemostasis, 2006
- Long-Term Follow-Up in 128 Patients With Primary Antiphospholipid SyndromeMedicine, 2005
- 10th International Congress on antiphospholipid antibodies—summaryAutoimmunity Reviews, 2003
- Antiphospholipid antibodies and thrombosis: strength of associationThe Hematology Journal, 2003
- International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: Report of an International workshopArthritis & Rheumatism, 1999
- Antiphospholipid Syndrome and ThrombosisSeminars in Thrombosis and Hemostasis, 1999
- Updating the American college of rheumatology revised criteria for the classification of systemic lupus erythematosusArthritis & Rheumatism, 1997
- 'Primary', 'Secondary' and Other Variants of the Antiphospholipid SyndromeLupus, 1994
- Heterogeneity of binding reactivity to different phospholipids of antibodies from patients with systemic lupus erythematosus (SLE) and with syphilisClinical and Experimental Immunology, 1990
- Thrombosis, abortion, cerebral disease, and the lupus anticoagulant.BMJ, 1983